• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Strategies for Tracking Patient Immunization Status


Dr Lewis discusses his organization’s leveraging of EMR to track immunization status of patients.

James Lewis, PharmD, FIDSA:The EMR [electronic medical record] can be a blessing and a curse. If you say electronic medical record, many physicians will start throwing things at you. But it can be an extremely useful tool if you have the organizational support to build the rules in it to fire reminders. On the inpatient side, we as an organization have very clear rules built in our EMR that trigger if a patient is due [for vaccination]. But those vaccination flags are there in the outpatient setting as well. I didn’t get reminded [at my doctor appointments], and I know for a fact that my personal chart has that Shingrix [vaccine for the prevention of shingles] message. Having a reminder built in to the EMR is not enough. Perhaps it needs a visual flag that says a patient is due for this. We could do a better job there.

The state of Oregon, where I live and practice, has a very cool database where individuals are supposed to report what vaccines patients received. That’s a huge help. Historically, 1 of the major problems has been that if I walk into pharmacy X, but I got my flu vaccine at pharmacy Z, then maybe there’s no way for pharmacy Z or X to know what has gone on at the other pharmacy. This is 1 of the struggles of not having better integration in our electronic medical records. This is another reason that we’d like to see that going forward, so other providers can see exactly what’s gone on. Until we reach a point in the adult space where vaccinations by other providers are more visible, we’re going to struggle. One public health wish list thing that I’d like to see is better cross-talk among EHRs [electronic health records]. We’re getting there, but it’s been a slow slog.

The ACIP [Advisory Committee on Immunization Practices] recommendations are possibly 1 of the most important things in vaccination practice that occur. Nothing, in our organization and in most organizations, moves until ACIP has blessed it. You’ve seen the CDC [Centers for Disease Control and Prevention] put it out in the official MMWR [Morbidity and Mortality Weekly Report]recommendations for adult and pediatric vaccinations. That triggers everything. If something isn’t in there, it’s not going to happen. This is 1 of the cornerstones of vaccination practice in the United States. That’s a really good thing. ACIP does a phenomenal job of being extremely evidence based, of meeting regularly, and being pretty darn transparent in why and how they’re doing what they’re doing. There have been times that I’ve wanted to throw objects at them—namely, the extremely confusing pneumococcal vaccination recommendations that made everybody want to gouge their eyes out for 5 to 10 years. Thankfully, they’ve improved those in the last couple of years with the arrival of new conjugate vaccines. But for me, for our organization, and for pretty much every organization that I’m aware of, if ACIP doesn’t move on it, it’s not going to happen. They’re extremely critical. Anybody interested in this space can follow them very easily. If you’re interested in this space, I highly encourage you to look at their meetings. They do a nice job.

Transcript edited for clarity.

Related Videos
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Video 3 - "Industry Collaboration in Shaping Digital Therapeutics Standards"
Video 6 - "Key Takeaways and Unmet Needs in Diabetes Treatment"
Video 5 - "Allocation of Investment and Value-Based Arrangements in Diabetes Care "
Related Content
© 2024 MJH Life Sciences

All rights reserved.